The absence of IL-6 or STAT3 signaling in chronic liver inflammation enhanced HCC development, leading to an increase in hepatic steatosis, macrophage accumulation, and hepatocyte proliferation [32]. This evidence concerns the gene IL6 and hepatocellular carcinoma.